Cargando…

Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation

AIM: Quantitative estimation of lercanidipine HCl in bulk material as well as from nanosuspension formulations via a developed reverse phase HPLC method. MATERIALS AND METHODS: Optimized chromatographic condition was used to achieve separation on a Kromasil (100-5c18 250 × 4.6 mm) column using Shima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chonkar, Ankita D., Managuli, Renuka S., Rao, Josyula Venkata, Udupa, Nayanabhirama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702276/ https://www.ncbi.nlm.nih.gov/pubmed/26792958 http://dx.doi.org/10.4103/0976-0105.170586

Ejemplares similares

Gastroretentive Pulsatile Release Tablets of Lercanidipine HCl: Development, Statistical Optimization, and In Vitro and In Vivo Evaluation
por: Reddy, Gagganapalli Santhoshi, et al.
Publicado: (2014)

A Fast, Stability-Indicating, and Validated Liquid Chromatography Method for the Purity Control of Lercanidipine Hydrochloride in Tablet Dosage Form
por: Mehta, Saumil, et al.
Publicado: (2014)

Preparation and Characterization of Novel PBAE/PLGA Polymer Blend Microparticles for DNA Vaccine Delivery
por: Balashanmugam, Meenashi Vanathi, et al.
Publicado: (2014)

Lercanidipine in Hypertension
por: Borghi, Claudio
Publicado: (2005)

Quantitative Determination of Lercanidipine Enantiomers in Commercial Formulations by Capillary Electrophoresis
por: Lourenço, Luciana Pereira, et al.
Publicado: (2015)

Spectrophotometric Determination of Labetalol and Lercanidipine in Pure Form and in Pharmaceutical Preparations Using Ferric-1,10-Phenanthroline
por: Abu El-Enin, M. A., et al.
Publicado: (2009)

Smart Polymers in Nasal Drug Delivery
por: Chonkar, Ankita, et al.
Publicado: (2015)

Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
por: Attimarad, M
Publicado: (2010)

Lercanidipine in the Management of Hypertension: An Update
por: Grassi, Guido, et al.
Publicado: (2017)

Formulation Strategies of Nanosuspensions for Various Administration Routes
por: Pınar, Sıla Gülbağ, et al.
Publicado: (2023)

New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023)

Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity
por: Ibrahim, Mohamed A., et al.
Publicado: (2019)

Nanoparticle Formulation Composition Analysis by Liquid Chromatography on Reversed-Phase Monolithic Silica
por: Tsarenko, Ekaterina, et al.
Publicado: (2022)

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation
por: Nakarani, M., et al.
Publicado: (2010)

Cyclosporine A-Nanosuspension: Formulation, Characterization and In Vivo Comparison with a Marketed Formulation
por: Nakarani, Mahendra, et al.
Publicado: (2010)

The effect of lercanidipine or lercanidipine/enalapril combination on blood pressure in treatment-naïve patients with stage 1 or 2 systolic hypertension
por: Rayner, Brian
Publicado: (2019)

Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride
por: Vasigar, Prathap, et al.
Publicado: (2013)

Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
por: Wang, Yonglu, et al.
Publicado: (2011)

Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019)

Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension
por: Zhao, Yingyuan, et al.
Publicado: (2023)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008)

Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
por: Pruijm, Menno T, et al.
Publicado: (2008)

Lercanidipine/enalapril combination in the management of obesity-related hypertension
por: Grassi, Guido
Publicado: (2016)

A Stability-indicating High Performance Liquid Chromatographic Assay for the Simultaneous Determination of Atenolol and Lercanidipine Hydrochloride in Tablets
por: Kaila, H. O., et al.
Publicado: (2011)

Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study
por: Detroja, Chetan, et al.
Publicado: (2011)

Reversed-phase High-performance Liquid Chromatography Method for Analysis of Curcuminoids and Curcuminoid-loaded Liposome Formulation
por: Jangle, R. D., et al.
Publicado: (2013)

Rapid Estimation of Tadalafil by Reverse-phase High-performance Liquid Chromatography Method in Bulk and Tablet Formulation
por: Sonawane, P. H., et al.
Publicado: (2013)

Assessment of cognitive function in patients with essential hypertension treated with lercanidipine
por: Tisaire-Sánchez, J, et al.
Publicado: (2006)

Management of lercanidipine overdose with hyperinsulinaemic euglycaemia therapy: case report
por: Hadjipavlou, George, et al.
Publicado: (2011)

Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells
por: Maliyakkal, Naseer, et al.
Publicado: (2021)

Formulation of Bilayer Benzydamine HCl Patch Targeted For Gingivitis
por: Sanghai, Piyush, et al.
Publicado: (2016)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery
por: Chiang, Po-Chang, et al.
Publicado: (2011)

Stereospecific Assay of (R)- and (S)-Goitrin in Commercial Formulation of Radix Isatidis by Reversed Phase High-Performance Liquid Chromatography
por: Nie, Lixing, et al.
Publicado: (2017)

Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design
por: B., Mishra, et al.
Publicado: (2010)

The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution
por: Rashed, Mahtab, et al.
Publicado: (2022)

Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021)

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
por: Antza, Christina, et al.
Publicado: (2016)

Formulation and evaluation of clindamycin HCL in situ gel for vaginal application
por: Patel, Priya, et al.
Publicado: (2015)

The Oral Administration of Lidocaine HCl Biodegradable Microspheres: Formulation and Optimization
por: ALQuadeib, Bushra T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1hh5md399nvm2p3n08l43u10mc